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Introduction: 
An efficient and representative mouse model is the corner stone of a successful experiment. The growing 
incidence of hepatocellular carcinoma (HCC) in the Western countries has led to an expanding interest of 
scientific research in this field. Therefore, there is a vast need of experimental models that mimic the natural 
pathogenesis of HCC in a short time period. Furthermore, the validation of an efficient imaging technique could 
contribute to the early detection of HCC in patients.  
 
 
Aim: 
The goal of our study was (1) to develop an efficient mouse model for hepatocellular carcinoma research, (2) to 
assess time-dependent angiogenic changes and (3) to investigate tumour growth and neo-vascularisation using 
state-of-the-art imaging techniques. 
 
 
Methods: 
5-week-old male mice received weekly intraperitoneal injections with N-nitrosodiethylamine (DEN) (35 mg/kg 
bodyweight) and samples were taken at several time points. Histology, ELISA and immunohistochemical 
stainings were used to identify the HCC-lesions and to quantify angiogenic factors VEGF and PlGF. HCC livers 
(25W) were perfused with Batson’s n°17 solution to produce vascular casts (arterial and venous). A state-of-the-
art multimodal microPET/CT was used for in vivo detection of HCC-lesions with [18F]-fluoromethylcholine 
([18F]FMCH) and for 3D-reconstruction of the vascular casts. 
 
 
Results: 
After 16W of DEN-injections a mild fibrosis (F1-F2) and dysplastic lesions appear, resulting in a pre-malignant 
environment. An increase of angiogenic factors VEGF and PlGF takes place, but not explicit enough to induce 
an increase in endothelial cells, which were upregulated after 20W. After 25W of DEN-injections, the dysplastic 
lesions have progressed to vascularised exophytic tumours which are macroscopically visible and give rise to a 
further increase in angiogenic factors, leading to the formation of new blood vessels. HCC-lesions were 
characterised by an increased uptake of [18F]FMCH, allowing visualisation of these hotspots (>3mm) with 
microPET/CT. The vascular casts of HCC-livers clearly revealed the chaotic pattern and hierarchically 
disorganisation of tumour induced blood vessels. Arteries formed a circumferential mantle around the hepatic 
tumours, while the central tumour regions showed a lower arterial density. 
 
 
Conclusion: 
While most DEN-induced models take at least one year to develop tumours, weekly injections with DEN give 
rise to tumour occurrence after 25W. The well vascularised orthotopic tumours are a representative model for 
HCC and can serve as an excellent platform for the development of new therapeutic targets. Furthermore, 
[18F]FMCH PET imaging may be clinically relevant for the visualization of HCC-lesions. 
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